CClinicalTrials.gg
CompletedNCT04069637Updated Jul 22, 2022

Serum and Urine Titanium Levels in Children With Early Onset Scoliosis Treated With Growth-Sparing Instrumentation

An observational study in Early-Onset Scoliosis Deformity of Spine, sponsored by University of Michigan. Completed at 1 site in United States. Open to participants aged 5 Years to 15 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-07-22.

Sponsored by University of Michigan · Observational

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
38
Ages
5 Years to 15 Years
Sex
All
01

Study summary

The investigators are conducting research to compare serum and urine titanium levels in children with early onset scoliosis who are being treated with certain types of metal spinal rods. These rods include traditional growing rods (TGR), magnetically-controlled growing rods (MCGR), and Vertical Expandable Prosthetic Titanium Rib (VEPTR). Children with metal rods may have elevated serum and urine titanium levels. These levels may remain elevated over time. The investigators will collect serum titanium levels from children with metal rods and children without metal rods to see if there are differences in their titanium levels. The investigators will then collect a second serum titanium level from children with metal rods at least 6 months later to see if the participants titanium levels remain elevated over time. The investigators will also collect urine titanium levels from children with metal rods to see if titanium is excreted in the urine.

02

Conditions studied

  • Early-Onset Scoliosis Deformity of Spine

Browse trials for

Keywords

  • Titanium Levels
03

In context

Scoliosis

594 studies on the registry are indexed under Scoliosis; 139 are open to participants now.

This study's enrollment of 38 is below the median of 89 across 233 observational studies indexed under Scoliosis.

Browse Scoliosis studies →

Lead sponsor

University of Michigan is the lead sponsor of 1,475 studies on the registry; 196 are open to participants now.

Of its 162 completed or terminated interventional studies of FDA-regulated products, 128 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
5 Years to 15 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The study population will be patients treated by the Pediatric Orthopaedic Surgery department at Michigan Medicine.

Inclusion criteria

Cases: Patients with early onset scoliosis treated with traditional growing rods (TGR), magnetically controlled growing rods (MCGR), and the Vertical Expandable Prosthetic Titanium Rib (VEPTR).

Controls: Patients with operative fractures.

Exclusion criteria

Exclusion Criteria:

Cases: Patients who had a previous limited spinal fusion, conversion from one type of GSI to another, TGR with stainless steel or cobalt chromium instrumentation, and indwelling implants for 6 months or less.

Controls: Patients with indwelling implants or prior implant insertion and removal.

05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
38 participants (actual)
Target follow-up
6 Months
Patient registry
Yes

Groups and cohorts

  • Early onset Scoliosis

    Patients with early onset scoliosis treated with growth-sparing instrumentation (TGR, MCGR, and, VEPTR).

    Combination Product: Growth-sparing instrumentation and titanium levels

  • Control group

    Patients with operative fractures.

Interventions

  • Combination productGrowth-sparing instrumentation and titanium levels

    Patients with growth-sparing instrumentation as treatment for early onset scoliosis, will have their titanium (serum and urine) levels tested, to evaluated if they have elevated titanium levels compared to a control group.

06

What researchers measure

Primary outcomes

  1. Serum titanium levels between groups

    Compare serum titanium levels in patients with EOS treated with titanium alloy TGR, MCGR, and VEPTR to age-matched controls.

    Time frame: At enrollment

  2. Serial serum titanium levels in scoliosis patients

    Collect serial serum titanium levels in patients with EOS treated with TGR, MCGR, and VEPTR.

    Time frame: Roughly 6 months apart

  3. Urine titanium levels in scoliosis patients

    Collect urine titanium levels in patients with EOS treated with TGR, MCGR, and VEPTR.

    Time frame: At enrollment

07

Study locations

1 site
  • Michigan Medicine
    Ann Arbor, Michigan 48109, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 22, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04069637
Lead sponsor
University of Michigan
Collaborators
Scoliosis Research Society
Responsible party
G Ying Li (Associate Professor Of Orthopaedic Surgery, University of Michigan) — Principal investigator
First posted
Aug 28, 2019
Start date
Nov 7, 2019
Primary completion
Jul 19, 2022
Completion
Jul 19, 2022
Last update
Jul 22, 2022

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion